0001640334-18-000725.txt : 20180515 0001640334-18-000725.hdr.sgml : 20180515 20180413172836 ACCESSION NUMBER: 0001640334-18-000725 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180413 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nemus Bioscience, Inc. CENTRAL INDEX KEY: 0001516551 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450692882 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 130 NORTH MARINA DRIVE CITY: LONG BEACH STATE: CA ZIP: 90803 BUSINESS PHONE: (949) 396-0330 MAIL ADDRESS: STREET 1: 130 NORTH MARINA DRIVE CITY: LONG BEACH STATE: CA ZIP: 90803 FORMER COMPANY: FORMER CONFORMED NAME: LOAD GUARD LOGISTICS, INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: LOAD GUARD TRANSPORTATION, INC. DATE OF NAME CHANGE: 20110324 CORRESP 1 filename1.htm nemus_corresp.htm

Nemus Bioscience, Inc.

600 Anton Blvd., Suite 1100

Costa Mesa, CA 92626

(949) 396-0330

 

April 13, 2018

 

VIA EDGAR

 

Division of Corporation Finance

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

 

Attention:

Mr. Chris Edwards

 

Re:

Nemus Bioscience, Inc.

Registration Statement on Form S-1

File No. 333-223895

 

Dear Mr. Edwards:

 

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Nemus Bioscience, Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-223895) (the “Registration Statement”). We respectfully request that the Registration Statement become effective as of 4:30 p.m., Eastern Time, on April 16, 2018, or as soon as practicable thereafter.

 

Once the Registration Statement has been declared effective, please orally confirm that event with our outside legal counsel, Greenberg Traurig, LLP, by calling Mark C. Lee at (916) 442-1111.

 

The Company acknowledges the following:

 

·

should the Securities and Exchange Commission (the “Commission”) or the staff of the Commission (the “Staff”), acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

 

·

the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

 

·

the Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

 

Thank you for your assistance with this matter. If you have any questions regarding the foregoing, please do not hesitate to contact Mark C. Lee of Greenberg Traurig, LLP at (916) 442-1111.

 

Sincerely,

 

Nemus Bioscience, Inc.

 

/s/ Brian S. Murphy

Brian S. Murphy

Chief Executive Officer

 

cc: Mark C. Lee, Greenberg Traurig, LLP